Skip to content

enGene Therapeutics Inc.

ENGN Nasdaq SEC CIK 1980845

Follow enGene Therapeutics Weekly email: filings, results, news

News

2 stories filed under enGene Therapeutics

Markets

Thread · 2 stories

enGene to Participate in Upcoming Investor Conferences

Markets 23 d ago

enGene Therapeutics Inc. (ENGN) Discusses Market Insights and Clinical Development in Non-Muscle Invasive Bladder Cancer - Slideshow

Markets 44 d ago

Profile

Headquarters: SAINT-LAURENT
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator